Search for: "Par Pharmaceutical" Results 41 - 60 of 303
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 May 2019, 11:00 am by Kevin LaCroix
On May 18, 2015 Endo announced that it would be acquiring Par Pharmaceutical, another generic drug company for over $8 billion. [read post]
12 May 2019, 11:00 am by Kevin LaCroix
On May 18, 2015 Endo announced that it would be acquiring Par Pharmaceutical, another generic drug company for over $8 billion. [read post]
15 Apr 2019, 7:19 pm by Scott McKeown
Par Pharmaceutical Inc., Nos. 14-1289-RGA, 14-1494-RGA, 15-0078-RGA (D. [read post]
11 Apr 2019, 4:00 am
This paper focuses specifically on developing countries and portrays some practical cases of technology transactions in the pharmaceutical industry (ELEA in Argentina; Beximco Pharmaceuticals Ltd in Bangladesh; Technoquimicas in Colombia;  SEAA  in Ethiopia; and Quality Chemicals in Uganda) to analyse the lessons and limitations of the licensing approach. [read post]
13 Dec 2018, 4:05 pm by Rik Lambers
MSD was granted an SPC for the product ezetimibe, if desired in the form of a pharmaceutically acceptable salt thereof, on the basis of its patent EP 0 720 599 (the Basic Patent). [read post]
31 Oct 2018, 5:09 pm by Kevin LaCroix
As I noted here, Allergan, Teva Pharmaceuticals, and Endo International (whose Par Pharmaceuticals unit is caught up in the investigation) – all three companies that have been identified by name in connection with the alleged generic drug price-fixing conspiracy – previously were hit with securities class action lawsuit related to the price-fixing investigation. [read post]
9 Sep 2018, 10:25 am by Patent Docs
Par Pharmaceutical, Inc. v. [read post]
3 Sep 2018, 9:16 pm by Patent Docs
Par Pharmaceutical, Inc. 1-18-cv-01224; filed August 10, 2018 in the District Court of Delaware • Plaintiff: Horizon Therapeutics, LLC • Defendants: Par Pharmaceuticals, Inc., Par Pharmaceutical Companies, Inc. [read post]
19 Jul 2018, 10:15 am by Mike Mireles
  Some research points to two causes of the high cost in the United States: 1) high pharmaceutical cost; and 2) high wages for health care workers.Notably, two pharmaceutical companies, Novartis and Pfizer, recently announced that they would not implement pharmaceutical price increases on certain drugs. [read post]
13 Jul 2018, 5:48 pm by Lawrence B. Ebert
Par Pharm., 773F.3d at 1195 (quoting In re Oelrich, 666 F.2d 578, 581(CCPA 1981)). [read post]
10 Jun 2018, 8:23 pm by Dennis Crouch
But as the leaders of numerous Indian tribes have told me, this treatment is par for the course. [read post]
21 Mar 2018, 1:34 pm by Pierre T. Nguyen
Une de ces unicités a récemment refait surface dans la décision du Federal Circuit dans Helsinn Healthcare SA v Teva Pharmaceuticals USA Inc.: la mise en vente pouvant faire anticiper un dépôt de brevet américain. [read post]
16 Mar 2018, 3:39 am by SHG
Drug dealing sentences have long been on par with murder sentences, under the simplistic assumption that ever-longer sentences will deter people from selling drugs. [read post]
18 Jan 2018, 9:34 am by m zamora
WARNING LETTERMark BaumImprimis Pharmaceuticals Inc.12264 El Camino Real, Suite 350San Diego, CA 92130Dear Mr. [read post]